Clinical Trials

New Search
Title   A Phase 1-2 Multi-Center Study Evaluating KTE-C19 in Subjects With Refractory Aggressive Non-Hodgkin Lymphoma (ZUMA-1) (ZUMA-1)
Disease/Condition   Blood and Bone Marrow Cancer
Eligibility Criteria   Ages Eligible for Study: 18 Years and older Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements
Principal Investigator   Ira Braunschweig, MD
Contact Name   Karen Fehn
Phone   (718) 405-8446
Contact Email
IRB/Protocol Number   IRB# 15-11-37-01
Status   Enrolling
Adult Clinical Trial   Yes
Pediatric Clinical Trial   No